http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2003252891-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8af19d05c71d306141bc1fdbd2f05f39 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H5-04 |
| filingDate | 2002-02-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a35318696e933981c9b7b2db7262c7af |
| publicationDate | 2003-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2003252891-A |
| titleOfInvention | Cytosaminomycin synthesis intermediate and method for producing the same |
| abstract | [PROBLEMS] To provide a synthetic intermediate of cytosaminomycin having anticoccidial activity, and a method for producing the same. A cytosaminomycin (Cytosamimycin) is provided. Various synthesis routes can be considered for synthesizing nomycin). The present inventors have conducted intensive studies for the purpose of developing a chemical synthesis method of cytosaminomycin, and as a result, first prepared a disaccharide derivative, and then reacted this compound with a cytosine derivative to obtain a cytosaminomycin. (Cytosami nomycin) The synthetic route via the synthetic intermediate is Cytosaminomyci The present inventors have found that the compound is effective for the synthesis of n) and arrived at the present invention. |
| priorityDate | 2002-02-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 46.